Herriot Tabuteau
Herriot Tabuteau | |
|---|---|
| Born | 1968 (age 57–58) Haiti |
| Citizenship | United States |
| Education | Bachelor of Arts, Wesleyan; Medical Doctor, Yale School of Medicine |
| Occupation | Founder of Axsome Therapeutics |
| Website | https://herriottabuteau.org/about/ |
Herriot Tabuteau is a Haitian American physician, businessman and entrepreneur. He founded Axsome Therapeutics Nasdaq: AXSM in 2012.[1][2]
Biography
Dr. Herriot Tabuteau immigrated from Haiti when he was nine years old.[1] Herriot grew up on the Upper East Side of Manhattan[3] He received his medical degree from Yale University School of Medicine and his bachelor's degree in molecular biology and biochemistry from Wesleyan University.[4]
Tabuteau worked in healthcare finance prior to founding Axsome. He was a partner at hedge fund Healthco/S.A.C. Capital.[5]
He took Axsome public in 2015.[6] His 22% stake and options were worth $465 million in 2021 according to Business Insider.[6] As of 2025, he owns 15%.[2][7]
He is listed as the inventor on over 200 patents.[4]
References
- ^ a b MFL, Taylor Carmichael, George Budwell, and Patrick (1 April 2022). "3 CEOs to Invest In". The Motley Fool.
{{cite web}}: CS1 maint: multiple names: authors list (link) - ^ a b Young, Jabari (2 April 2025). "The World's Black Billionaires 2025". Forbes. Archived from the original on 3 April 2025.
- ^ ."About". HerriotTabuteauMD. Archived from the original on 14 April 2025.
- ^ a b "Herriot Tabuteau". Forbes. Archived from the original on 6 September 2025. Retrieved 2025-05-26.
- ^ "Herriot Tabuteau — Profile". realtimebillionaires.de. Archived from the original on 6 September 2025.
- ^ a b Cuccinello, Hayley (29 March 2021). "Meet Dr. Herriot Tabuteau, an elusive doctor whose $2.2 billion pharma company could improve life for millions of people with Alzheimer's". Business Insider. Archived from the original on 30 March 2021.
- ^ "The World's Black billionaires in 2025". Daily News on African Billionaires and UHNWIs. 1 April 2025. Archived from the original on 26 July 2025.